image
Healthcare - Biotechnology - NASDAQ - US
$ 34.86
-0.143 %
$ 19.6 B
Market Cap
14.23
P/E
Price Target Average
36.46%
Revenue Forecast Estimate
19.35%
EBIT Estimate
21.10%
Net Income Estimate
55.53%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Royalty Pharma plc
image
Wall Street analysts predict an average 1-year price target for RPRX of $47.6 , with forecasts ranging from a low of $28 to a high of $51 .
RPRX Lowest Price Target Wall Street Target
28 USD -19.68%
RPRX Average Price Target Wall Street Target
47.6 USD 36.46%
RPRX Highest Price Target Wall Street Target
51 USD 46.30%
Price
Max Price Target
Min Price Target
Average Price Target
55555050454540403535303025252020Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart RPRX

image
$5.0b$5.0b$4.5b$4.5b$4.0b$4.0b$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RPRX

image
$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RPRX

image
$6.0b$6.0b$5.0b$5.0b$4.0b$4.0b$3.0b$3.0b$2.0b$2.0b$1.0b$1.0b$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029